Dapagza 10 Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dapagza 10 Tablet
Empagliflozin 10mg tablets are indicated, either singularly or in conjunction with other therapies, for the management of type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the likelihood of severe diabetic complications and contributing to cardiovascular protection. Empagliflozin 10mg can be administered with or without food, consistently at the same time daily, as directed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation may lead to elevated blood sugar and risks such as nephropathy and vision impairment. This medication forms part of a comprehensive treatment plan encompassing dietary adjustments, physical activity, and weight management, as advised by your doctor. Common adverse reactions include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Increased fluid loss is possible; adequate hydration is crucial to prevent dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption, as it may exacerbate certain side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapagza 10 Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Dapagza 10 Tablet
Managing type 2 diabetes
Major Benefits of Dapagza 10 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Dapagza 10mg tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dapagza 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapagza 10 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Dapagza 10mg tablets can be administered with or without food, however, consistent timing is recommended.
How Dapagza 10 Tablet works:
Dapagliflozin 10 mg tablets are used to manage diabetes. Their mechanism of action involves eliminating surplus glucose via urinary excretion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Dapagza 10 Tablet should not be consumed together.
PregnancyCONSULT YOUR DOCTOR
Using Dapagza 10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapagza 10mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
The use of Dapagza 10 mg tablets is contraindicated in individuals with impaired renal function and should be strictly avoided. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapagliflozin 10 mg tablets can be used safely by individuals with hepatic impairment. No alteration of the dapagliflozin 10 mg tablet dosage is advised.
What if you forget to take Dapagza 10 Tablet :
Should you forget to take your Dapagza 10 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapagza 10 Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |


